Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.

NCT NCT05044819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05044819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Lead sponsor
Jazz Pharmaceuticals
Phase
Phase 4
Overall status
Active, not recruiting
Start date
July 7, 2021
Completion date
March 31, 2028
Enrollment
154 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome, lennox gastaut syndrome, tuberous sclerosis complex